BC
IMGN

Boxer Capital’s Immunogen Inc IMGN Stock Holding History

Boxer Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,961,000
Closed -$87.8M – 63
2023
Q4 		$87.8M Hold
2,961,000
– – 4.38% 8
2023
Q3 		$47M Hold
2,961,000
– – 2.5% 13
2023
Q2 		$55.9M Buy
+2,961,000
New +$35M 2.59% 11

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Boxer Capital's IMGN Position: Q1 2024 in Review

Boxer Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 2,961,000 shares — an estimated $87.8M sold.

Boxer Capital first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $87.8M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Boxer Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Boxer Capital sold 2,961,000 Immunogen Inc shares in Q1 2024, an estimated $87.8M.
  • Boxer Capital first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
  • Boxer Capital's Immunogen Inc position peaked at $87.8M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Boxer Capital's 13F filing for Q1 2024, filed 15 May 2024.